DarioHealth Corp. financial data

Symbol
DRIO on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
322 W 57 Th St. #33 B, New York, NY
State of incorporation
DE
Fiscal year end
December 31
Former names
LabStyle Innovations Corp. (to 7/27/2016)
Latest financial report
10-K - Q4 2024 - Mar 10, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 229 % -52.8%
Quick Ratio 27.6 % -45.1%
Return On Equity -61.8 % +28.1%
Return On Assets -35 % +36.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 41.6M shares +41.2%
Common Stock, Shares, Outstanding 38.4M shares +41.2%
Entity Public Float 31M USD -68.4%
Common Stock, Value, Issued 4K USD +33.3%
Weighted Average Number of Shares Outstanding, Basic 49M shares +72.8%
Weighted Average Number of Shares Outstanding, Diluted 49M shares +72.8%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 24.2M USD +19.4%
General and Administrative Expense 20.5M USD +12.9%
Operating Income (Loss) -57.7M USD -2.77%
Nonoperating Income (Expense) 13.1M USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -44.6M USD +24.9%
Income Tax Expense (Benefit) -13K USD
Net Income (Loss) Attributable to Parent -42.7M USD +28.1%
Earnings Per Share, Basic 0.61 USD/shares -68.4%
Earnings Per Share, Diluted 0.61 USD/shares -68.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 27.8M USD -24.5%
Inventory, Net 4.75M USD -6.1%
Other Assets, Current 289K USD +15.6%
Assets, Current 40.5M USD -14.4%
Property, Plant and Equipment, Net 709K USD -21.1%
Operating Lease, Right-of-Use Asset 1.07M USD +10.1%
Intangible Assets, Net (Excluding Goodwill) 18.8M USD +247%
Goodwill 57.4M USD +37.9%
Assets 119M USD +23.3%
Employee-related Liabilities, Current 4.11M USD +0.96%
Accrued Liabilities, Current 1.94M USD -12.9%
Contract with Customer, Liability, Current 1.58M USD +58.8%
Liabilities, Current 16.6M USD +33.2%
Deferred Income Tax Liabilities, Net 4.17M USD +71.8%
Operating Lease, Liability, Noncurrent 765K USD -13.6%
Other Liabilities, Noncurrent 25K USD -30.6%
Retained Earnings (Accumulated Deficit) -390M USD -11.7%
Stockholders' Equity Attributable to Parent 72M USD +23.9%
Liabilities and Equity 119M USD +23.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -13.1M USD -176%
Net Cash Provided by (Used in) Financing Activities 20.2M USD
Net Cash Provided by (Used in) Investing Activities -8.85M USD -103%
Common Stock, Shares Authorized 160M shares 0%
Common Stock, Shares, Issued 38.4M shares +41.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 27.8M USD -24.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 986K USD -8.02%
Deferred Tax Assets, Valuation Allowance 77.2M USD +32.4%
Deferred Tax Assets, Gross 81.4M USD +34%
Operating Lease, Liability 1.27M USD +27.4%
Depreciation 110K USD +13.4%
Payments to Acquire Property, Plant, and Equipment 56K USD -24.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -41M USD +35.5%
Lessee, Operating Lease, Liability, to be Paid 1.46M USD +14.9%
Property, Plant and Equipment, Gross 2.62M USD +9.72%
Operating Lease, Liability, Current 504K USD +354%
Lessee, Operating Lease, Liability, to be Paid, Year Two 376K USD +23.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 525K USD +323%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 192K USD -30.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 277K USD -0.72%
Preferred Stock, Shares Issued 49.6K shares +162%
Preferred Stock, Shares Authorized 5M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 283K USD +1.43%
Additional Paid in Capital 462M USD +13.5%
Preferred Stock, Shares Outstanding 49.6K shares +162%
Amortization of Intangible Assets 1.22M USD +9.25%
Deferred Tax Assets, Net of Valuation Allowance 4.17M USD +71.8%
Share-based Payment Arrangement, Expense 6.86M USD +41.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%